UNSPSC 85416304: The diagnosis of abnormal findings in specimens from other organs, systems and tissues : abnormal level of substances chiefly nonmedicinal as to source

In this classification, this covers the group of activities that yields a diagnosis of abnormal findings in specimens from other organs, systems and tissues: abnormal level of substances chiefly nonmedicinal as to source. Abnormal findings in specimens from other organs, systems and tissues: abnormal level of substances chiefly nonmedicinal as to source is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems (ICD-10) as a four-character category under code R89.3.

UNSPSC 85416304 Diagnosis of abnormal findings in specimens from other organs, systems and tissues: abnormal level of substances chiefly nonmedicinal as to source is a Commodity code that does not align with recent state and local procurement activity. The three most recent opportunities tagged under this code involve diagnostic imaging system procurement, special education contracted services, and health professional staffing — none of which are specimen diagnosis or laboratory analyte services. The code shows little relevant recent activity for the work its abstract scope describes.

The mismatch between the nominal scope and posted opportunities suggests that state and local procurement offices are applying this code incorrectly or using it as a catchall for health system diagnostics work more broadly. San Mateo Medical Center's Picture Archiving and Communication System RFP (due October 21, 2026) solicits enterprise imaging software and implementation; Birdville Independent School District's special education services RFQ (due October 21, 2026) covers speech therapy, audiology, and related disciplines; and Santa Clara Health System's temporary staffing RFQ (due October 7, 2026) establishes a qualified vendor pool for ancillary clinical roles including diagnostic imaging and audiology. None of these opportunities are specimen-based diagnostics. Business development teams evaluating this code should verify coding accuracy with issuing bodies before pursuing, as the recent activity does not support the code's stated commodity definition.